Drug Information

Drug General Information
Drug ID
D03JLK
Former ID
DNC014375
Drug Name
Ac-FWKY-NH2
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530610]
Structure
Download
2D MOL

3D MOL
Formula
C37H45N7O6
Canonical SMILES
CC(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)N<br />C(CCCCN)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)N
InChI
1S/C37H45N7O6/c1-23(45)41-32(20-24-9-3-2-4-10-24)36(49)44-33(21-26-22-40-29-12-6-5-11-28(26)29)37(50)42-30(13-7-8-18-38)35(48)43-31(34(39)47)19-25-14-16-27(46)17-15-25/h2-6,9-12,14-17,22,30-33,40,46H,7-8,13,18-21,38H2,1H3,(H2,39,47)(H,41,45)(H,42,50)(H,43,48)(H,44,49)/t30-,31-,32-,33-/m0/s1
InChIKey
YBFQDCKGFBIRPS-YRCZKMHPSA-N
PubChem Compound ID
10985299
Target and Pathway
Target(s) Urotensin II receptor Target Info Inhibitor [530610]
KEGG Pathway Neuroactive ligand-receptor interaction
Reactome Peptide ligand-binding receptors
G alpha (q) signalling events
WikiPathways Gastrin-CREB signalling pathway via PKC and MAPK
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 530610J Med Chem. 2010 Apr 8;53(7):2695-708.Urotensin-II receptor modulators as potential drugs.
Ref 530610J Med Chem. 2010 Apr 8;53(7):2695-708.Urotensin-II receptor modulators as potential drugs.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.